(Br5) Peripheral Ivus
Payments companies reported to CMS as associated with (Br5) Peripheral Ivus. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with (Br5) Peripheral Ivus, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with (Br5) Peripheral Ivus
These are the largest totals companies reported as associated with (Br5) Peripheral Ivus. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hyun Bang | Brandywine, MD | Vascular & Interventional Radiology | $638.16 |
| Matthew Kilbridge | Brandywine, MD | Vascular & Interventional Radiology | $638.09 |
| Neerav Shah | Wellington, FL | Cardiovascular Disease | $538.23 |
| Joseph Karam | Minneapolis, MN | Vascular Surgery | $516.03 |
| Tariq Haddadin | Johnson City, TN | Interventional Cardiology | $447.15 |
| Brian Allen | Brighton, CO | Cardiovascular Disease | $397.82 |
| Andrei Gursky | Takoma Park, MD | Thoracic Surgery (Cardiothoracic Vascular Surgery) | $379.26 |
| Lawrence Goldstein | Napa, CA | Vascular Surgery | $343.16 |
| Huseng Vefali | Austin, TX | Interventional Cardiology | $315.40 |
| Elizabeth Cunningham | Napa, CA | Surgery | $312.12 |
Prescribed (Br5) Peripheral Ivus?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.